Onconova Therapeutics (ONTX)

Onconova Therapeutics (ONTX) Stock Price & Analysis


ONTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.62 - $1.49
Previous Close$0.79
Average Volume (3M)55.67K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$29.73M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.8
Nov 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding20,977,625
10 Day Avg. Volume40,143
30 Day Avg. Volume55,672
Standard Deviation0.38
Financial Highlights & Ratios
Price to Book (P/B)0.90
Price to Sales (P/S)288.90
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside1046.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Onconova Therapeutics’s price range in the past 12 months?
Onconova Therapeutics lowest stock price was $0.62 and its highest was $1.49 in the past 12 months.
    What is Onconova Therapeutics’s market cap?
    Currently, no data Available
    When is Onconova Therapeutics’s upcoming earnings report date?
    Onconova Therapeutics’s upcoming earnings report date is Nov 15, 2023 which is in 54 days.
      How were Onconova Therapeutics’s earnings last quarter?
      Onconova Therapeutics released its earnings results on Aug 10, 2023. The company reported -$0.2 earnings per share for the quarter, beating the consensus estimate of -$0.312 by $0.112.
        Is Onconova Therapeutics overvalued?
        According to Wall Street analysts Onconova Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Onconova Therapeutics pay dividends?
          Onconova Therapeutics does not currently pay dividends.
          What is Onconova Therapeutics’s EPS estimate?
          Onconova Therapeutics’s EPS estimate is -$0.29.
            How many shares outstanding does Onconova Therapeutics have?
            Onconova Therapeutics has 20,977,625 shares outstanding.
              What happened to Onconova Therapeutics’s price movement after its last earnings report?
              Onconova Therapeutics reported an EPS of -$0.2 in its last earnings report, beating expectations of -$0.312. Following the earnings report the stock price went down -5.882%.
                Which hedge fund is a major shareholder of Onconova Therapeutics?
                Currently, no hedge funds are holding shares in ONTX


                Onconova Therapeutics Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Onconova Therapeutics

                Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.


                Top 5 ETFs holding ONTX

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold ONTX. The ETFs are listed according to market value of ONTX within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Cyclacel Pharmaceuticals
                Kala Pharmaceuticals
                Aptose Biosciences

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis